Predictive Value of Immunologic and Virologic Markers After Long or Short Duration of HIV‐1 Infection

Summary: Laboratory markers that predict HIV‐1 disease progression include plasma viral burden, CD4+ T‐cell count, and CD38 expression on CD8 T cells. To better understand whether the predictive value of these markers is dependent on how long an individual has been infected, we analyzed data from the Multicenter AIDS Cohort Study early (median = 2.8 years) and late (median = 8.7 years) in the course of infection. Overall, we found that HIV RNA and CD38 levels were similarly predictive of AIDS early on compared with a relatively weaker CD4 cell count signal. Later in the course of infection, CD38 level remained the strongest predictive marker and CD4 cell count registered a marked increase in prognostic power. Among untreated individuals, there was little difference in prognosis (median time to AIDS) associated with given marker values regardless of infection duration. The prognosis given a specific viral load level tended to deteriorate late in the course of infection among those undergoing treatment with monotherapy or combination therapy, however. These data provide a unique historical look at the predictive value and prognostic significance of HIV‐1 disease markers at different stages of infection in a large cohort, with direct relevance to current patients who are untreated or for whom treatment is ineffective.

[1]  M. Prins,et al.  Early and late HIV‐1 RNA level and its association with other markers and disease progression in long‐term AIDS‐free homosexual men , 1997, AIDS.

[2]  J. Lundgren,et al.  Longitudinal serum HIV RNA quantification: correlation to viral phenotype at seroconversion and clinical outcome , 1996, AIDS.

[3]  J. Phair,et al.  The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants. , 1987, American journal of epidemiology.

[4]  B. Clotet,et al.  Lack of evidence of a stable viral load set‐point in early stage asymptomatic patients with chronic HIV‐1 infection , 1998, AIDS.

[5]  R. Detels,et al.  Prognostic significance of plasma markers of immune activation, HIV viral load and CD4 T‐cell measurements , 1998, AIDS.

[6]  R. Detels,et al.  CD8+ T-lymphocyte activation in HIV-1 disease reflects an aspect of pathogenesis distinct from viral burden and immunodeficiency. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[7]  J J Goedert,et al.  Natural history of HIV-1 cell-free viremia. , 1995, JAMA.

[8]  A. Fauci,et al.  The immunopathogenesis of human immunodeficiency virus infection. , 1993, The New England journal of medicine.

[9]  J. Margolick,et al.  Evaluation of a dual-color flow cytometry immunophenotyping panel in a multicenter quality assurance program. , 1993, Cytometry.

[10]  R H Lyles,et al.  Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men. Multicenter AIDS Cohort Study. , 2000, The Journal of infectious diseases.

[11]  J V Giorgi,et al.  Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. , 1999, The Journal of infectious diseases.

[12]  J. Margolick,et al.  Quality control in the flow cytometric measurement of T-lymphocyte subsets: the multicenter AIDS cohort study experience. The Multicenter AIDS Cohort Study Group. , 1990, Clinical immunology and immunopathology.

[13]  R. Brookmeyer,et al.  Factors associated with prevalent human immunodeficiency virus (HIV) infection in the Multicenter AIDS Cohort Study. , 1987, American journal of epidemiology.

[14]  J. Margolick,et al.  Effects of Anticoagulant, Processing Delay, and Assay Method (Branched DNA versus Reverse Transcriptase PCR) on Measurement of Human Immunodeficiency Virus Type 1 RNA Levels in Plasma , 1999, Journal of Clinical Microbiology.

[15]  A. Muñoz,et al.  Models for the incubation of AIDS and variations according to age and period. , 1996, Statistics in medicine.

[16]  P. Harrigan,et al.  Prospective longitudinal analysis of viral load and surrogate markers in relation to clinical progression in HIV type 1-infected persons. , 1997, AIDS research and human retroviruses.

[17]  J. Goedert,et al.  Plasma HIV Viral Load in Patients with Hemophilia and Late-Stage HIV Disease: A Measure of Current Immune Suppression , 1999, Annals of Internal Medicine.

[18]  J V Giorgi,et al.  Quantitation of CD38 activation antigen expression on CD8+ T cells in HIV-1 infection using CD4 expression on CD4+ T lymphocytes as a biological calibrator. , 1998, Cytometry.

[19]  Roger Detels,et al.  Plasma Viral Load and CD4+ Lymphocytes as Prognostic Markers of HIV-1 Infection , 1997, Annals of Internal Medicine.

[20]  J. Chmiel,et al.  Estimation of time since exposure for a prevalent cohort. , 1992, Statistics in medicine.